These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 730384)

  • 21. Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection.
    Hobden JA; Masinick SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1107-14. PubMed ID: 7730020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Barrett RP; McClellan S; Hazlett LD
    J Leukoc Biol; 2001 Dec; 70(6):911-9. PubMed ID: 11739554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody hyporesponsiveness in resistant BALB/cJ mice intracorneally infected with Pseudomonas aeruginosa.
    Berk RS; Preston M; Montgomery IN; Hazlett LD; Tse HY
    Reg Immunol; 1990-1991; 3(4):186-92. PubMed ID: 2129603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.
    McClellan SA; Huang X; Barrett RP; van Rooijen N; Hazlett LD
    J Immunol; 2003 May; 170(10):5219-27. PubMed ID: 12734370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.
    Hobden JA; Masinick SA; Barrett RP; Hazlett LD
    Infect Immun; 1997 Jul; 65(7):2754-8. PubMed ID: 9199446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A.
    Hazlett LD; Berk RS; Iglewski BH
    Infect Immun; 1981 Dec; 34(3):1025-35. PubMed ID: 6800950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious agents in immunodeficient murine models: pathogenicity of Nocardia asteroides in congenitally athymic (nude) and hereditarily asplenic (Dh/+) mice.
    Beaman BL; Gershwin ME; Maslan S
    Infect Immun; 1978 May; 20(2):381-7. PubMed ID: 352942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging alters the phagocytic capability of inflammatory cells induced into cornea.
    Hazlett LD; Kreindler FB; Berk RS; Barrett R
    Curr Eye Res; 1990 Feb; 9(2):129-38. PubMed ID: 2335110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation.
    Szliter EA; Lighvani S; Barrett RP; Hazlett LD
    J Immunol; 2007 Jan; 178(2):1105-14. PubMed ID: 17202374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa.
    Preston MJ; Kernack K; Berk RS
    Infect Immun; 1993 Jun; 61(6):2713-6. PubMed ID: 8500912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontline Science: Employing enzymatic treatment options for management of ocular biofilm-based infections.
    Kugadas A; Geddes-McAlister J; Guy E; DiGiandomenico A; Sykes DB; Mansour MK; Mirchev R; Gadjeva M
    J Leukoc Biol; 2019 Jun; 105(6):1099-1110. PubMed ID: 30690787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected with P. aeruginosa.
    Dong Z; Katar M; Alousi S; Berk RS
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3223-7. PubMed ID: 11726626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascularization of corneas of hairless mutant mice.
    Niederkorn JY; Ubelaker JE; Martin JM
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):948-53. PubMed ID: 1692313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on defense mechanisms against Candida albicans infection in congenitally athymic nude (nu/nu) mice.
    Tabeta H; Mikami Y; Abe F; Ommura Y; Arai T
    Mycopathologia; 1984 Feb; 84(2-3):107-13. PubMed ID: 6717553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa.
    Cole N; Bao S; Willcox M; Husband AJ
    Infect Immun; 1999 May; 67(5):2497-502. PubMed ID: 10225913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of adhesion, piliation, protease production and ocular infectivity of several P. aeruginosa strains.
    Hazlett LD; Moon MM; Singh A; Berk RS; Rudner XL
    Curr Eye Res; 1991 Apr; 10(4):351-62. PubMed ID: 1676963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection.
    Khan S; Cole N; Hume EB; Garthwaite L; Conibear TC; Miles DH; Aliwaga Y; Krockenberger MB; Willcox MD
    J Leukoc Biol; 2007 Jan; 81(1):315-8. PubMed ID: 17028201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intercellular adhesion molecule-2 (ICAM-2) and Pseudomonas aeruginosa ocular infection.
    Hobden JA
    DNA Cell Biol; 2003 Oct; 22(10):649-55. PubMed ID: 14611686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.